Balchem Corporation (BCPC) Key Metrics
BCPC valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $5.44B
- Enterprise value
- $5.47B
- P/E (TTM)
- 33.6 10-yr median 41.5
- Forward P/E
- 29.3
- PEG ratio
- 3.26
- Price / sales
- 5.0 10-yr median 5.0
- Price / book
- 4.1 10-yr median 4.5
- EV / EBITDA
- 20.3 10-yr median 22.9
- Dividend yield
- 0.56% $0.96 a year
- Beta
- 0.85
BCPC key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsBCPC valuation Price multiples at each fiscal year-end price.
BCPC returns How much profit the business earns on the capital it uses.
BCPC per-share figures Results divided by the shares outstanding at year-end.
BCPC financial health Debt, liquidity and how easily interest is covered.
BCPC efficiency & capital use Working capital cycle and where the cash goes.
BCPC valuation history
BCPC returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
BCPC debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
BCPC cash returned to shareholders
BCPC price vs earnings per share
BCPC key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $5.00B | $5.33B | $4.83B | $3.96B | $5.51B | $3.74B | $3.30B | $2.54B | $2.60B | $2.68B |
| Enterprise value | $5.12B | $5.49B | $5.09B | $4.35B | $5.53B | $3.84B | $3.50B | $2.64B | $2.78B | $2.93B |
| P/E ratio | 32.3 | 41.5 | 44.5 | 37.5 | 57.3 | 44.3 | 41.5 | 32.4 | 28.8 | 47.9 |
| Price / sales | 4.8 | 5.6 | 5.2 | 4.2 | 6.9 | 5.3 | 5.1 | 3.9 | 4.4 | 4.8 |
| Price / book | 4.0 | 4.6 | 4.6 | 4.2 | 6.3 | 4.5 | 4.4 | 3.7 | 4.2 | 5.1 |
| Price / free cash flow | 28.9 | 36.4 | 33.1 | 44.8 | 44.8 | 32.1 | 34.4 | 25.7 | 31.5 | 32.0 |
| Price / operating cash flow | 23.1 | 29.3 | 26.3 | 28.6 | 34.3 | 24.9 | 26.5 | 21.4 | 23.5 | 24.9 |
| EV / sales | 4.9 | 5.8 | 5.5 | 4.6 | 6.9 | 5.5 | 5.4 | 4.1 | 4.7 | 5.3 |
| EV / EBITDA | 20.1 | 23.8 | 23.7 | 22.2 | 31.3 | 23.7 | 23.6 | 17.5 | 19.8 | 21.5 |
| EV / free cash flow | 29.6 | 37.5 | 34.9 | 49.3 | 44.9 | 32.9 | 36.4 | 26.7 | 33.7 | 35.0 |
| Earnings yield | 3.1% | 2.4% | 2.2% | 2.7% | 1.7% | 2.3% | 2.4% | 3.1% | 3.5% | 2.1% |
| Free cash flow yield | 3.5% | 2.7% | 3.0% | 2.2% | 2.2% | 3.1% | 2.9% | 3.9% | 3.2% | 3.1% |
| Dividend yield | 0.6% | 0.5% | 0.5% | 0.5% | 0.3% | 0.4% | 0.5% | 0.5% | 0.5% | 0.4% |
| Shareholder yield (dividends + buybacks) | 2.7% | 0.6% | 0.6% | 1.4% | 1.0% | 0.8% | 1.1% | 0.6% | 0.5% | 0.5% |
| Share price at fiscal year-end | $153.36 | $163.00 | $148.75 | $122.11 | $168.60 | $115.22 | $101.63 | $78.35 | $80.60 | $83.92 |
| Per share | ||||||||||
| Revenue per share | $31.81 | $29.15 | $28.43 | $29.09 | $24.46 | $21.65 | $19.80 | $19.84 | $18.45 | $17.33 |
| Earnings per share | $4.75 | $3.93 | $3.35 | $3.25 | $2.94 | $2.60 | $2.45 | $2.42 | $2.79 | $1.75 |
| Operating cash flow per share | $6.64 | $5.56 | $5.66 | $4.28 | $4.91 | $4.63 | $3.83 | $3.66 | $3.43 | $3.37 |
| Free cash flow per share | $5.31 | $4.47 | $4.50 | $2.72 | $3.77 | $3.59 | $2.95 | $3.05 | $2.56 | $2.62 |
| Cash per share | $2.29 | $1.51 | $1.99 | $2.05 | $3.16 | $2.60 | $2.02 | $1.67 | $1.25 | $1.21 |
| Book value per share | $38.57 | $35.15 | $32.48 | $28.97 | $26.84 | $25.48 | $22.88 | $21.32 | $19.14 | $16.32 |
| Tangible book value per share | $8.52 | $6.26 | $2.58 | −$1.37 | $7.91 | $5.45 | $2.33 | $4.24 | $1.47 | −$2.08 |
| Dividends per share | $0.87 | $0.78 | $0.70 | $0.64 | $0.57 | $0.51 | $0.47 | $0.41 | $0.37 | $0.34 |
| Capex per share | $1.33 | $1.09 | $1.17 | $1.55 | $1.15 | $1.04 | $0.87 | $0.61 | $0.87 | $0.75 |
| Debt per share | $5.89 | $6.36 | $10.18 | $14.22 | $3.81 | $5.43 | $7.96 | $4.81 | $6.98 | $9.00 |
| Shares outstanding | 32.6M | 32.7M | 32.4M | 32.4M | 32.7M | 32.5M | 32.5M | 32.4M | 32.2M | 31.9M |
| Change in shares outstanding | −0.3% | +0.8% | +0.2% | −0.9% | +0.5% | −0.0% | +0.2% | +0.7% | +1.0% | +0.9% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 12.9% | 11.7% | 10.9% | 11.6% | 11.3% | 10.8% | 11.1% | 12.0% | 15.8% | 11.4% |
| Return on invested capital (ROIC) | 12.7% | 10.7% | 9.5% | 10.3% | 10.8% | 9.5% | 9.8% | 10.7% | 12.3% | 8.5% |
| Return on assets (ROA) | 9.4% | 8.1% | 6.7% | 7.5% | 8.1% | 7.3% | 7.5% | 8.1% | 9.4% | 6.1% |
| Return on tangible assets | 21.3% | 20.4% | 17.3% | 16.4% | 16.5% | 16.4% | 16.3% | 18.4% | 22.8% | 15.5% |
| Free cash flow margin | 16.7% | 15.3% | 15.8% | 9.4% | 15.4% | 16.6% | 14.9% | 15.4% | 13.9% | 15.1% |
| Income quality (OCF / net income) | 1.40 | 1.42 | 1.69 | 1.31 | 1.67 | 1.78 | 1.56 | 1.51 | 1.23 | 1.92 |
| Financial health | ||||||||||
| Total debt | $192.0M | $208.0M | $330.3M | $460.6M | $124.6M | $176.4M | $258.9M | $156.0M | $224.8M | $287.4M |
| Cash & short-term investments | $74.6M | $49.5M | $64.4M | $66.6M | $103.2M | $84.6M | $65.7M | $54.3M | $40.4M | $38.6M |
| Net debt | $117.4M | $158.5M | $265.9M | $394.1M | $21.4M | $91.9M | $193.2M | $101.7M | $184.4M | $248.7M |
| Debt / equity | 0.15 | 0.18 | 0.31 | 0.49 | 0.14 | 0.21 | 0.35 | 0.23 | 0.36 | 0.55 |
| Debt / assets | 0.11 | 0.13 | 0.21 | 0.28 | 0.10 | 0.15 | 0.22 | 0.16 | 0.23 | 0.30 |
| Net debt / EBITDA | 0.46 | 0.69 | 1.24 | 2.01 | 0.12 | 0.57 | 1.30 | 0.67 | 1.31 | 1.82 |
| Current ratio | 2.07 | 1.99 | 2.12 | 2.40 | 2.24 | 2.83 | 2.76 | 2.76 | 1.84 | 1.87 |
| Quick ratio | 1.33 | 1.16 | 1.38 | 1.54 | 1.61 | 2.08 | 1.85 | 1.94 | 1.28 | 1.30 |
| Interest coverage | 21.4 | 11.1 | 7.0 | 14.1 | 51.9 | 25.0 | 17.2 | 14.1 | 12.8 | 12.5 |
| Working capital | $189.2M | $156.1M | $165.8M | $195.8M | $178.4M | $172.5M | $162.7M | $144.3M | $90.9M | $87.4M |
| Invested capital | $1.37B | $1.31B | $1.32B | $1.33B | $898.4M | $920.1M | $936.9M | $793.4M | $801.3M | $769.8M |
| Tangible asset value | $277.7M | $204.8M | $83.9M | −$44.5M | $258.4M | $177.1M | $75.7M | $137.6M | $47.4M | −$66.3M |
| Net current asset value | −$84.5M | −$111.7M | −$229.0M | −$350.4M | −$78,000 | −$70.7M | −$157.1M | −$63.4M | −$147.4M | −$239.2M |
| Graham number | $64.20 | $55.72 | $49.44 | $46.04 | $42.15 | $38.64 | $35.52 | $34.08 | $34.69 | $25.37 |
| Graham net-net per share | −$6.20 | −$6.75 | −$10.17 | −$14.24 | −$2.62 | −$4.43 | −$7.21 | −$3.92 | −$6.44 | −$9.33 |
| Capital allocation | ||||||||||
| Dividends paid | $28.3M | $25.6M | $22.9M | $20.7M | $18.7M | $16.7M | $15.1M | $13.4M | $12.1M | $10.7M |
| Share buybacks (net) | $107.6M | $5.7M | $4.5M | $35.4M | $35.2M | $13.5M | $21.3M | $1.4M | $1.9M | $1.6M |
| Dividend payout ratio | 18.3% | 19.9% | 21.1% | 19.7% | 19.5% | 19.7% | 19.0% | 17.1% | 13.4% | 19.2% |
| Dividends + buybacks / free cash flow | 78.5% | 21.4% | 18.7% | 63.6% | 43.8% | 25.9% | 38.0% | 15.0% | 16.9% | 14.7% |
| Capex / revenue | 4.2% | 3.7% | 4.1% | 5.3% | 4.7% | 4.8% | 4.4% | 3.1% | 4.7% | 4.3% |
| Capex / operating cash flow | 20.1% | 19.6% | 20.6% | 36.3% | 23.3% | 22.5% | 22.8% | 16.6% | 25.4% | 22.3% |
| Capex / depreciation | 0.95 | 0.74 | 0.69 | 0.97 | 0.77 | 0.66 | 0.62 | 0.44 | 0.63 | 0.52 |
| Stock-based compensation / revenue | 1.7% | 1.7% | 1.7% | 1.4% | 1.4% | 1.2% | 1.2% | 1.0% | 1.1% | 1.3% |
| R&D / revenue | 1.8% | 1.8% | 1.6% | 1.3% | 1.7% | 1.5% | 1.8% | 1.8% | 1.6% | 1.3% |
| SG&A / revenue | 6.5% | 14.3% | 14.1% | 13.1% | 12.8% | 14.6% | 15.1% | 13.2% | 13.9% | 14.9% |
| Efficiency | ||||||||||
| Days sales outstanding | 46.3 | 46.9 | 50.8 | 48.2 | 49.2 | 49.7 | 54.7 | 54.1 | 53.5 | 47.4 |
| Days of inventory on hand | 71.8 | 71.0 | 67.4 | 58.1 | 53.1 | 58.8 | 63.8 | 53.1 | 53.0 | 50.6 |
| Days payables outstanding | 31.5 | 32.6 | 33.2 | 31.3 | 26.3 | 23.2 | 30.0 | 25.8 | 27.4 | 23.1 |
| Cash conversion cycle (days) | 86.6 | 85.3 | 85.1 | 75.0 | 76.1 | 85.3 | 88.5 | 81.4 | 79.2 | 74.9 |
| Receivables turnover | 7.88 | 7.79 | 7.18 | 7.57 | 7.41 | 7.34 | 6.67 | 6.75 | 6.82 | 7.70 |
| Payables turnover | 11.57 | 11.20 | 11.00 | 11.66 | 13.90 | 15.73 | 12.17 | 14.12 | 13.31 | 15.77 |
| Inventory turnover | 5.08 | 5.14 | 5.41 | 6.28 | 6.88 | 6.21 | 5.72 | 6.87 | 6.88 | 7.21 |
| Asset turnover | 0.63 | 0.60 | 0.57 | 0.67 | 0.68 | 0.61 | 0.60 | 0.66 | 0.62 | 0.60 |
| Average receivables | $131.6M | $122.5M | $128.4M | $124.5M | $107.8M | $95.8M | $96.5M | $95.4M | $87.2M | $71.9M |
| Average payables | $57.6M | $55.1M | $56.4M | $56.8M | $40.0M | $30.5M | $35.5M | $31.1M | $30.5M | $23.6M |
| Average inventory | $131.1M | $120.2M | $114.6M | $105.4M | $80.8M | $77.3M | $75.5M | $63.9M | $59.0M | $51.7M |
| Intangibles / total assets | 57.4% | 60.0% | 60.7% | 60.5% | 51.6% | 55.8% | 57.8% | 56.5% | 59.1% | 61.9% |
Computed from BCPC's annual financial statements (latest annual report filed February 20, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
BCPC valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Balchem traded at 32.3 times earnings, against a 10-year median of 41.5. Based on the latest twelve months, the trailing P/E is 33.6 and the forward P/E is 29.3. Balchem earned a return on equity of 12.9% and a return on invested capital of 12.7% in fiscal 2025. It ended the year with $192.0 million of debt and $74.6 million in cash and short-term investments, net debt of $117.4 million. It returned $135.9 million to shareholders: $28.3 million in dividends and $107.6 million in share buybacks, 79% of free cash flow.
See the BCPC income statement, the BCPC chart for price history, or the BCPC stock overview for the latest quote and news.
BCPC key metrics FAQ
What is Balchem's P/E ratio?
Balchem's trailing P/E ratio is 33.6 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 29.3. At the end of fiscal 2025 it was 32.3, compared with a 10-year median of 41.5.
What is Balchem's EV/EBITDA?
Balchem's enterprise value was 20.1 times EBITDA at the end of fiscal 2025 (enterprise value $5.1 billion, EBITDA $254.9 million); the current EV/EBITDA is 20.3.
What is Balchem's return on equity?
Balchem's return on equity (ROE) was 12.9% in fiscal 2025: net income of $154.8 million on average shareholders' equity of $1.2 billion.
What is Balchem's ROIC?
Balchem's return on invested capital was 12.7% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Balchem have?
Balchem had total debt of $192.0 million at the end of fiscal 2025, a debt-to-equity ratio of 0.15 and $117.4 million of net debt (0.46 times EBITDA).
What is Balchem's dividend yield?
Balchem's forward dividend yield is 0.56%. Balchem paid $28.3 million in dividends in fiscal 2025 ($0.87 per share), a payout ratio of 18.3%.
Does Balchem buy back its shares?
Yes. Balchem spent $107.6 million on net share repurchases in fiscal 2025 Shares outstanding changed −0.3% over the year, to 32.6M..
What is Balchem's free cash flow yield?
Balchem generated $173.1 million of free cash flow in fiscal 2025, a free cash flow yield of 3.5% on its market value at year-end ($5.0 billion).
What is Balchem's current ratio?
Balchem's current ratio was 2.07 at the end of fiscal 2025: current assets were 2.07 times current liabilities.